Thrombolysis-related hemorrhagic infarction -: A marker of early reperfusion, reduced infarct size, and improved outcome in patients with proximal middle cerebral artery occlusion

被引:207
作者
Molina, CA
Alvarez-Sabín, J
Montaner, J
Abilleira, S
Arenillas, JF
Coscojuela, P
Romero, F
Codina, A
机构
[1] Hosp Valle De Hebron, Dept Neurol, Cerebrovasc Unit, Barcelona 08035, Spain
[2] Hosp Valle De Hebron, Dept Neuroradiol, Cerebrovasc Unit, Barcelona 08035, Spain
关键词
hemorrhage; reperfusion; thrombolysis; ultrasonography;
D O I
10.1161/01.STR.0000016323.13456.E5
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-The role of early and delayed recanalization after thrombolysis in the development of hemorrhagic transformation (HT) subtypes remains uncertain. We sought to explore the association between the timing of recanalization and HT risk in patients with proximal middle cerebral artery (MCA) occlusion treated with intravenous recombinant tissue plasminogen activator (rtPA) <3 hours of stroke onset and to investigate the relationship between HT subtypes, infarct volume, and outcome. Methods-Thirty-two patients with acute stroke caused by proximal MCA occlusion treated with rtPA <3 hours of symptom onset were prospectively studied. Serial transcranial Doppler examinations were performed on admission and at 6, 12, 24, and 48 hours. Presence and type of HT were assessed on CT at 36 to 48 hours. Modified Rankin scale was used to assess outcome at 3 months. Results-Early and delayed recanalization was identified in 17 patients (53.1%) and 8 patients (25%), respectively. HT was detected in 14 patients (43.7%): 4 (12.5%) with hemorrhagic infarction (HI1), 5 (15.6%) with HI2, 3 (9.3%) with parenchymal hematoma (PH1,), and 2 (6.8%) with PH2. Distribution of HT subtypes differed significantly (P=0.025), depending on the time to artery reopening. Eight of 9 (89%), 1 of 5 (20%), and 8 of 18 (44.4%) with HI1-HI2, with PH1-PH2, and without HT, respectively, recanalized in <6 hours. Delayed recanalization was observed in 1 patient with HI1-HI2 (11%), 4 with PH1-PH2 (80%), and 3 without HT (16.6%). Neurological improvement was significantly (P<0.001) more frequent in patients with HI1-HI2 (88%) than in those without HT (39%). Infarct volume was significantly (P<0.031) lower in patients with HI1-HI2 (51.4 +/- 42 cm) than,in patients with PH1-PH2 (83.8 +/- 48 cm(3)) and those without HT (98.4 +/- 84 cm(3), P=0.021). The modified Rankin scale score was significantly lower in HI1-HI2 compared with PH1-PH2 patients (1.9 +/- 1.1 versus 4.6 +/- 1.2, P<0.00 1) and with those without HT (1.9 +/- 1.1 versus 3.5 +/- 2.0, P=0.009.). Conclusions-Thrombolysis-related HI (HI1-HI2) represents a marker of early successful recanalization, which leads to a reduced infarct size and improved clinical outcome.
引用
收藏
页码:1551 / 1556
页数:6
相关论文
共 39 条
[1]   Hemorrhagic transformation of ischemic brain tissue -: Asymptomatic or symptomatic? [J].
Berger, C ;
Fiorelli, M ;
Steiner, T ;
Schäbitz, WR ;
Bozzao, L ;
Bluhmki, E ;
Hacke, W ;
von Kummer, R .
STROKE, 2001, 32 (06) :1330-1335
[2]   Reperfusion and metabolic recovery of brain tissue and clinical outcome after ischemic stroke and thrombolytic therapy [J].
Berrouschot, J ;
Barthel, H ;
Hesse, S ;
Knapp, WH ;
Schneider, D ;
von Kummer, R .
STROKE, 2000, 31 (07) :1545-1551
[3]   Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke [J].
Brott, T ;
Broderick, J ;
Kothari, R ;
ODonoghue, M ;
Barsan, W ;
Tomsick, T ;
Spilker, J ;
Miller, R ;
Sauerbeck, L ;
Farrell, J ;
Kelly, J ;
Perkins, T ;
Miller, R ;
McDonald, T ;
Rorick, M ;
Hickey, C ;
Armitage, J ;
Perry, C ;
Thalinger, K ;
Rhude, R ;
Schill, J ;
Becker, PS ;
Heath, RS ;
Adams, D ;
Reed, R ;
Klei, M ;
Hughes, A ;
Anthony, J ;
Baudendistel, D ;
Zadicoff, C ;
Rymer, M ;
Bettinger, I ;
Laubinger, P ;
Schmerler, M ;
Meiros, G ;
Lyden, P ;
Dunford, J ;
Zivin, J ;
Rapp, K ;
Babcock, T ;
Daum, P ;
Persona, D ;
Brody, M ;
Jackson, C ;
Lewis, S ;
Liss, J ;
Mahdavi, Z ;
Rothrock, J ;
Tom, T ;
Zweifler, R .
STROKE, 1997, 28 (11) :2109-2118
[4]   Transcranial Doppler ultrasound criteria for recanalization after thrombolysis for middle cerebral artery stroke [J].
Burgin, WS ;
Malkoff, M ;
Felberg, RA ;
Demchuk, AM ;
Christou, I ;
Grotta, JC ;
Alexandrov, AV .
STROKE, 2000, 31 (05) :1128-1132
[5]   Timing of recanalization after tissue plasminogen activator therapy determined by transcranial Doppler correlates with clinical recovery from ischemic stroke [J].
Christou, I ;
Alexandrov, AV ;
Burgin, WS ;
Wojner, AW ;
Felberg, RA ;
Malkoff, M ;
Grotta, JC .
STROKE, 2000, 31 (08) :1812-1816
[6]   The rtPA (Alteplase) 0-to 6-hour acute stroke trial, part A (A0276g) - Results of a double-blind, placebo-controlled, multicenter study [J].
Clark, WM ;
Albers, GW ;
Madden, KP ;
Hamilton, S .
STROKE, 2000, 31 (04) :811-816
[7]   Ischaemic damage of brain microvessels: inherent risks for thrombolytic treatment in stroke [J].
del Zoppo, GJ ;
Von Kummer, R ;
Hamann, GF .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 65 (01) :1-9
[8]   PROACT: A phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke [J].
del Zoppo, GJ ;
Higashida, RT ;
Furlan, AJ ;
Pessin, MS ;
Rowley, HA ;
Gent, M .
STROKE, 1998, 29 (01) :4-11
[9]   Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke [J].
Demchuk, AM ;
Morgenstern, LB ;
Krieger, DW ;
Chi, TL ;
Hu, W ;
Wein, TH ;
Hardy, RJ ;
Grotta, JC ;
Buchan, AM .
STROKE, 1999, 30 (01) :34-39
[10]   Delayed rt-PA treatment in a rat embolic stroke model: Diagnosis and prognosis of ischemic injury and hemorrhagic transformation with magnetic resonance imaging [J].
Dijkhuizen, RM ;
Asahi, M ;
Wu, O ;
Rosen, BR ;
Lo, EH .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2001, 21 (08) :964-971